Autoimmune Diseases

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio

Participate in a Study

There are several trials under way at Seattle Cancer Alliance for autoimmune diseases. Current trials are open are for adults with Multiple Sclerosis, Systemic Sclerosis, Systemic Lupus Erythematosus and rare neurological disorders. Current trials open for pediatric autoimmune diseases include Pediatric Systemic Sclerosis, Juvenile Rheumatoid Arthritis, Juvenile Dermatomyocitis and Juvenile Systemic Lupus Erythematosus.

Patients who participate in clinical trials have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about the disease. Although clinical trials may pose some risk, researchers take careful steps to protect people who take part. For more information on clinical trials, a patient should talk to his or her doctor.

Clinical trials come in four phases. In Phase I trials, researchers try to determine safe dose levels. In Phase II trials, which involve a larger group of patients, researchers hope to build on what they learned in the first phase by trying to establish whether cancers will respond to the safe dose levels and to determine what side effects will occur. In Phase III trials, researchers compare the experimental treatment with the standard treatment or a placebo to prove whether the new treatment is truly effective. In Phase IV trials, researchers monitor the effects of long-term usage.

Browse an open clinical trial on the SCCA Clinical Trials Database.

For more information about clinical studies, see the Patient Guide to Clinical Trials which includes Myths vs Facts.